QQQ   311.72 (+3.59%)
AAPL   150.82 (+3.71%)
MSFT   264.60 (+4.69%)
META   188.77 (+23.28%)
GOOGL   107.74 (+7.28%)
AMZN   112.91 (+7.38%)
TSLA   188.27 (+3.78%)
NVDA   217.09 (+3.66%)
NIO   11.96 (-1.16%)
BABA   109.74 (-2.73%)
AMD   88.31 (+4.34%)
T   20.28 (+0.50%)
MU   63.17 (+0.91%)
F   14.32 (+3.84%)
CGC   3.14 (+1.95%)
GE   83.94 (+1.97%)
DIS   113.21 (+3.49%)
AMC   6.08 (+6.48%)
PFE   44.34 (+0.84%)
PYPL   86.96 (+4.88%)
NFLX   366.89 (+1.35%)
QQQ   311.72 (+3.59%)
AAPL   150.82 (+3.71%)
MSFT   264.60 (+4.69%)
META   188.77 (+23.28%)
GOOGL   107.74 (+7.28%)
AMZN   112.91 (+7.38%)
TSLA   188.27 (+3.78%)
NVDA   217.09 (+3.66%)
NIO   11.96 (-1.16%)
BABA   109.74 (-2.73%)
AMD   88.31 (+4.34%)
T   20.28 (+0.50%)
MU   63.17 (+0.91%)
F   14.32 (+3.84%)
CGC   3.14 (+1.95%)
GE   83.94 (+1.97%)
DIS   113.21 (+3.49%)
AMC   6.08 (+6.48%)
PFE   44.34 (+0.84%)
PYPL   86.96 (+4.88%)
NFLX   366.89 (+1.35%)
QQQ   311.72 (+3.59%)
AAPL   150.82 (+3.71%)
MSFT   264.60 (+4.69%)
META   188.77 (+23.28%)
GOOGL   107.74 (+7.28%)
AMZN   112.91 (+7.38%)
TSLA   188.27 (+3.78%)
NVDA   217.09 (+3.66%)
NIO   11.96 (-1.16%)
BABA   109.74 (-2.73%)
AMD   88.31 (+4.34%)
T   20.28 (+0.50%)
MU   63.17 (+0.91%)
F   14.32 (+3.84%)
CGC   3.14 (+1.95%)
GE   83.94 (+1.97%)
DIS   113.21 (+3.49%)
AMC   6.08 (+6.48%)
PFE   44.34 (+0.84%)
PYPL   86.96 (+4.88%)
NFLX   366.89 (+1.35%)
QQQ   311.72 (+3.59%)
AAPL   150.82 (+3.71%)
MSFT   264.60 (+4.69%)
META   188.77 (+23.28%)
GOOGL   107.74 (+7.28%)
AMZN   112.91 (+7.38%)
TSLA   188.27 (+3.78%)
NVDA   217.09 (+3.66%)
NIO   11.96 (-1.16%)
BABA   109.74 (-2.73%)
AMD   88.31 (+4.34%)
T   20.28 (+0.50%)
MU   63.17 (+0.91%)
F   14.32 (+3.84%)
CGC   3.14 (+1.95%)
GE   83.94 (+1.97%)
DIS   113.21 (+3.49%)
AMC   6.08 (+6.48%)
PFE   44.34 (+0.84%)
PYPL   86.96 (+4.88%)
NFLX   366.89 (+1.35%)
NASDAQ:GOVX

GeoVax Labs - GOVX News Today

$0.92
+0.02 (+2.22%)
(As of 02/2/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.85
$0.96
50-Day Range
$0.55
$1.11
52-Week Range
$0.53
$4.30
Volume
1.00 million shs
Average Volume
4.34 million shs
Market Capitalization
$24.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.50
Get GeoVax Labs News Delivered to You Automatically

Sign up to receive the latest news and ratings for GOVX and its competitors with MarketBeat's FREE daily newsletter.



GOVX Media Mentions By Week

GOVX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GOVX
News Sentiment

0.00

0.49

Average
Medical
News Sentiment

GOVX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GOVX Articles
This Week

3

1

GOVX Articles
Average Week

SourceHeadline
finanznachrichten.de logoGeoVax, Inc.: GeoVax Receives Notice of Allowance for Zika Vaccine Patent
finanznachrichten.de - January 29 at 8:33 AM
MarketBeat logoGeoVax Labs, Inc. (NASDAQ:GOVX) Short Interest Up 105.3% in January
americanbankingnews.com - January 29 at 7:02 AM
finance.yahoo.com logoGeoVax to Present at the 2023 BIO CEO & Investor Conference
finance.yahoo.com - January 26 at 9:56 AM
finance.yahoo.com logoGeoVax Receives Notice of Allowance for Zika Vaccine Patent
finance.yahoo.com - January 25 at 1:30 PM
finance.yahoo.com logoGeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2023
finance.yahoo.com - January 4 at 10:37 AM
finance.yahoo.com logoValerie Montgomery Rice, MD, FACOG, President and CEO of Morehouse School of Medicine, Appointed Special Advisor to GeoVax
finance.yahoo.com - December 20 at 9:49 AM
finance.yahoo.com logoGeoVax Appoints Jayne Morgan, M.D., to its Board of Directors
finance.yahoo.com - December 7 at 4:22 PM
finance.yahoo.com logoGeoVax to Present at the World Vaccine & Immunotherapy Congress West Coast 2022
finance.yahoo.com - November 28 at 11:41 AM
markets.businessinsider.com logoH.C. Wainwright Keeps Their Buy Rating on GeoVax Labs (GOVX)
markets.businessinsider.com - November 11 at 8:04 AM
finance.yahoo.com logoGeoVax Labs Third Quarter 2022 Earnings: US$0.17 loss per share (vs US$0.31 loss in 3Q 2021)
finance.yahoo.com - November 11 at 8:04 AM
seekingalpha.com logoGeoVax Labs, Inc. (GOVX) Q3 2022 Earnings Call Transcript
seekingalpha.com - November 9 at 8:52 PM
finance.yahoo.com logoWill GeoVax Labs (NASDAQ:GOVX) Spend Its Cash Wisely?
finance.yahoo.com - October 31 at 11:25 AM
finance.yahoo.com logoGeoVax to Present at Upcoming Investor Conferences
finance.yahoo.com - October 6 at 10:34 AM
finance.yahoo.com logoGeoVax to Present at the H.C. Wainwright 24th Annual Global Investment Conference
finance.yahoo.com - September 7 at 10:42 AM
finance.yahoo.com logoGeoVax Announces Addition to Its Board of Directors
finance.yahoo.com - September 1 at 9:53 AM
investorplace.com logoGeoVax Labs Stock Has a Lot More Than Hype Behind Its Recent Surge
investorplace.com - August 9 at 8:02 AM
uk.investing.com logoShort Volatility Alert: GeoVax Labs, Inc.
uk.investing.com - July 29 at 5:26 AM
finance.yahoo.com logoGeoVax Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate Against Sudan Ebolavirus Showing 100% Protection With a Single Immunization
finance.yahoo.com - July 28 at 9:19 AM
finance.yahoo.com logoGeoVax to Report Second Quarter 2022 Financial Results on Wednesday, August 3, 2022 and Provide Corporate Update
finance.yahoo.com - July 26 at 9:58 AM
barrons.com logoThinking about buying stock in Synthetic Biologics, Revelation Biosciences, Geovax Labs, Chimerix, or Zymergen?
barrons.com - July 25 at 11:19 PM
uk.investing.com logoPre-Open Movers: Monkeypox Plays Jump on WHO Warning; Weber Falls on Weak Results
uk.investing.com - July 25 at 2:55 PM
finance.yahoo.com logoAtlanta company GeoVax raises more money for Covid-19 vaccine, cancer treatment trials
finance.yahoo.com - July 8 at 3:17 PM
seekingalpha.com logoGOVX GeoVax Labs, Inc.
seekingalpha.com - July 1 at 10:19 PM
seekingalpha.com logoCDC announces emergency operations center for monkeypox
seekingalpha.com - June 28 at 4:49 PM
finance.yahoo.com logoGeoVax to Present at BIO International Convention 2022
finance.yahoo.com - June 7 at 3:34 PM
seekingalpha.com logoGeoVax Labs falls 27% on direct offering
seekingalpha.com - May 25 at 4:43 PM
finance.yahoo.com logoGeoVax Announces $20 Million Registered Direct and PIPE Offerings Priced at a Premium to Market Under Nasdaq Rules
finance.yahoo.com - May 25 at 4:43 PM
seekingalpha.com logoGeoVax stock soars on notice of allowance for cancer vaccine patent in China
seekingalpha.com - May 24 at 1:10 PM
finance.yahoo.com logoGeoVax Labs (NASDAQ:GOVX) Will Have To Spend Its Cash Wisely
finance.yahoo.com - May 24 at 10:38 AM
finance.yahoo.com logoMonkeypox cases drove up stock prices for these companies on Monday
finance.yahoo.com - May 24 at 10:38 AM
finance.yahoo.com logoGeoVax Receives Notice of Allowance for Cancer Vaccine Patent in China
finance.yahoo.com - May 24 at 10:38 AM
finance.yahoo.com logoBioMed Stocks On the Move: GeoVax Labs, Nova Mentis, SIGA and PharmaDrug; Life Sciences Leaders Report Latest Advances in Antiviral Vaccines, and Novel Therapeutics for Oncology, Glaucoma and Autism
finance.yahoo.com - May 23 at 5:07 PM
finance.yahoo.com logoMonkeypox cases are driving up stock prices for these companies
finance.yahoo.com - May 23 at 5:06 PM
bizjournals.com logo052022 B Small Public Co Reynolds CFO
bizjournals.com - May 20 at 4:33 AM
seekingalpha.com logoGeoVax Labs, Inc (GOVX) CEO David A. Dodd on Q1 2022 Results - Earnings Call Transcript - Earnings Call Transcript
seekingalpha.com - April 27 at 9:12 PM
finance.yahoo.com logoGeoVax Reports 2022 First Quarter Financial Results and Provides Corporate Update
finance.yahoo.com - April 27 at 4:12 PM
benzinga.com logoGeovax Labs's Earnings Outlook
benzinga.com - April 26 at 5:08 PM
finance.yahoo.com logoGeoVax Labs Stock Jumps On US Patent For Malaria Vaccine Candidate
finance.yahoo.com - April 26 at 5:08 PM
benzinga.com logoGeoVax Labs Shares Spike Higher; Co Announces Issuance Of Malaria Vaccine Patent
benzinga.com - April 26 at 12:05 PM
finance.yahoo.com logoGeoVax Announces Issuance of Malaria Vaccine Patent
finance.yahoo.com - April 26 at 12:05 PM
finance.yahoo.com logoGeoVax to Report First Quarter 2022 Financial Results on Wednesday, April 27, 2022 and Provide Corporate Update
finance.yahoo.com - April 19 at 9:55 AM
finance.yahoo.com logoAura FAT Projects Acquisition Corp. Announces Closing of Initial Public Offering and Exercise of Full Over-Allotment Option
finance.yahoo.com - April 18 at 7:08 PM
finance.yahoo.com logoCORRECTION - Aura FAT Projects Acquisition Corp. Announces Closing of Initial Public Offering and Exercise of Full Over-Allotment Option
finance.yahoo.com - April 18 at 7:08 PM
finance.yahoo.com logoGeoVax to Participate in Expert Panel Discussion on Pan-Corona and Universal Vaccines at the World Vaccine Congress
finance.yahoo.com - April 12 at 11:03 AM
baystreet.ca logoGeoVax Gains on Patent Developments on Cancer Drug
baystreet.ca - March 22 at 3:21 PM
finance.yahoo.com logoGeoVax Announces Issuance of Cancer Vaccine Patent
finance.yahoo.com - March 22 at 9:16 AM
finance.yahoo.com logoGeoVax to Present COVID-19 Vaccine Data at the Vaccine Summit Boston 2022
finance.yahoo.com - March 21 at 11:59 AM
finance.yahoo.com logoGeoVax to Participate in Maxim Group’s 2022 Virtual Growth Conference
finance.yahoo.com - March 16 at 10:00 AM
reuters.com logoGeoVax vaccine targeting virus in two places shows promise; virus may become resistant to antibody drugs
reuters.com - March 11 at 4:35 PM
finance.yahoo.com logoData Published in a Lancet Journal on COH04S1, a City of Hope-Developed COVID-19 Vaccine, Shows it Produced Robust Antibodies and T cells Against SARS-CoV-2
finance.yahoo.com - March 10 at 1:47 PM
Get GeoVax Labs News Delivered to You Automatically

Sign up to receive the latest news and ratings for GOVX and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:GOVX) was last updated on 2/2/2023 by MarketBeat.com Staff